The adaptive response of melanoma cells to BRAF inhibition implicates force‐induced actomyosin cytoskeletal remodeling (Kim et al, 2016; Girard et al, 2020; Orgaz et al, 2020). This evidence concerns the gene BRAF and melanoma.